Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study

BACKGROUND: The survival benefits of adrenalectomy (ADx) in the setting of metastatic cancer and prognostic factors for recurrence-free (RFS) and overall survival (OS) after adrenalectomy for metastatic carcinoma are still under debate. We evaluated the impact of clinicopathological variables on RFS...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Eu Chang, Hwang, Insang, Jung, Seung Il, Kang, Taek Won, Kwon, Dong Deuk, Heo, Suk Hee, Hwang, Jun Eul, Kang, Sung Gu, Kang, Seok Ho, Lee, Jeong Gu, Kim, Je Jong, Cheon, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035762/
https://www.ncbi.nlm.nih.gov/pubmed/24885814
http://dx.doi.org/10.1186/1471-2490-14-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035762/
https://www.ncbi.nlm.nih.gov/pubmed/24885814
http://dx.doi.org/10.1186/1471-2490-14-41

Ejemplares similares